Anlon Healthcare bulk deals, insider trading and stake changes
NSE: AHCLBSE: 544497Pharmaceuticals & BiotechnologySmall Cap
Anlon Healthcare Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2025 · Issue price ₹91
Last close ₹24.47up ₹0.06 (0.25%)BSE ₹24.44
Share price at the NSE close on 28 Oct 2026. Previous close ₹24.41.
28 Oct: open ₹24.10, high ₹24.99, low ₹23.60
52-week range of traded prices to 28 Oct 2026
₹10.37Low, 2 Mar 2026₹37.24High, 30 Sep 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,301 Cr1,681st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.76
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 5.65
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 13.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 39,97,777
Anlon Healthcare's insiders have 8 trade disclosures on record, the latest on 7 Oct 2026. Its promoter group made no purchase or sale on the market in the 12 months to 28 Oct 2026.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Anlon Healthcare promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Anlon Healthcare insider trading
Sep 2026
- Meet Atulkumar Vachhani₹127 Cr3,68,35,650 sharesBought · Promoter And Designated Person · 30 Sep 2026 · disclosed 7 Oct
- Punitkumar R Rasadia₹413 Cr11,94,91,650 sharesSold or invoked · Promoter And Designated Person · 30 Sep 2026 · disclosed 7 Oct
- Meet Atulkumar Vachhani₹127 Cr3,68,35,650 sharesSold or invoked · Promoter And Designated Person · 30 Sep 2026 · disclosed 7 Oct
- Punitkumar R Rasadia₹413 Cr11,94,91,650 sharesBought · Promoter And Designated Person · 30 Sep 2026 · disclosed 7 Oct
- Punitkumar R Rasadia₹27 Cr1,32,76,850 sharesSold or invoked · Promoter And Designated Person · 16 Sep 2026 · disclosed 1 Oct
- Meet Atulkumar Vachhani₹8.20 Cr40,92,850 sharesSold or invoked · Promoter And Designated Person · 16 Sep 2026 · disclosed 1 Oct
- Meet Atulkumar Vachhani₹8.20 Cr40,92,850 sharesBought · Promoter And Designated Person · 16 Sep 2026 · disclosed 1 Oct
- Punitkumar R Rasadia₹27 Cr1,32,76,850 sharesBought · Promoter And Designated Person · 16 Sep 2026 · disclosed 1 Oct
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Anlon Healthcare stake sales and purchases
All 10 disclosures on record.
Apr 2026
- BonusEach share became 2 on 24 Apr 2026. The lines below are on the share count before it.
- SplitEach share became 5 on 24 Apr 2026. The lines below are on the share count before it.
Mar 2026
- SoldNeomile Growth Fund - Series I0.76% of the company4,07,255 sharesholds 4.40% after10 Mar 2026 · filed under the 2% rule · Open Market
Nov 2025
- SoldNeomile Growth Fund-Series 1, Neomile Corporate Advisory Ltd2.78% of the company14,75,992 sharesholds 7.62% after4 Nov 2025 · filed under the 2% rule · Open Market
- SoldNeomile Growth Fund - Series I, Neomile Corporate Advisory Limited2.78% of the company14,75,992 sharesholds 7.62% after4 Nov 2025 · filed under the 2% rule · Open Market
Sep 2025
- SoldNeomile Growth Fund - Series I, Neomile Corporate Advisory Limited2.51% of the company13,32,594 sharesholds 10.40% after24 Sep 2025 · filed under the 2% rule · Open Market
- AcquiredNeomile Corporate Advisory Limited4.24% of the company22,54,422 sharesholds 12.91% after11 Sep 2025 · filed under the 2% rule · Open Market
- SoldAstorne Capital VCC - Arven and Astorne Capital VCC - Alpha A24.78% of the company25,42,924 sharesholds 4.49% after9 Sep 2025 · filed under the 2% rule · Open Market
- AcquiredNeomile Corporate Advisory Ltd & Neomile Grouth fund-Series8.67% of the company46,06,839 sharesholds 8.67% after5 Sep 2025 · filed under the 5% rule · Open Market
- AcquiredNeomile Asset Manager Private ltd8.67% of the company46,06,839 sharesholds 8.67% after5 Sep 2025 · filed under the 5% rule · Open Market
- AcquiredAstome Capital VCC-Arven, Astome Capital VCC-Alpha A29.28% of the company49,30,241 sharesholds 9.28% after1 Sep 2025 · filed under the 5% rule · Public Issue
- AcquiredAstorne Capital VCC - Arven and Astorne Capital VCC - Alpha A29.28% of the company49,30,241 sharesholds 9.28% after1 Sep 2025 · filed under the 5% rule · Public Issue
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Anlon Healthcare bulk deals
Last 12 months, since 28 Oct 2025: 104 bulk deals, ₹624 Cr bought and ₹664 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 8 Oct 20261 firm · ₹15 Cr bought · ₹17 Cr soldNet sold ₹2.31 Cr
- Both waysNEO APEX SHARE BROKING SERVICES LLPBought 54,17,160 at ₹26.78Sold 62,71,530 at ₹26.811.18% of the companyNet −8,54,370 shares₹15 Cr bought
Tuesday 6 Oct 20261 firm · ₹17 Cr bought · ₹4.23 Cr soldNet bought ₹13 Cr
- Both waysNEO APEX SHARE BROKING SERVICES LLPBought 58,58,505 at ₹29.70Sold 14,21,173 at ₹29.761.10% of the companyNet +44,37,332 shares₹17 Cr bought
Wednesday 30 Sep 20261 firm · ₹18 Cr bought · ₹9.35 Cr soldNet bought ₹8.70 Cr
- Both waysNEO APEX SHARE BROKING SERVICES LLPBought 52,08,869 at ₹34.66Sold 27,01,691 at ₹34.620.98% of the companyNet +25,07,178 shares₹18 Cr bought
Tuesday 29 Sep 20261 firm · ₹6.37 Cr bought · ₹10 Cr soldNet sold ₹3.64 Cr
- Both waysNEO APEX SHARE BROKING SERVICES LLPBought 17,50,000 at ₹36.39Sold 27,50,000 at ₹36.390.52% of the companyNet −10,00,000 shares₹6.37 Cr bought
Friday 25 Sep 20265 firms · ₹58 Cr bought · ₹58 Cr soldNet sold ₹0.54 Cr
- Both waysQE SECURITIES LLPBought 27,13,853 at ₹29.72Sold 28,25,885 at ₹29.870.53% of the companyNet −1,12,032 shares₹8.07 Cr bought
- Both waysHRTI PRIVATE LIMITEDBought 72,25,426 at ₹30.10Sold 72,44,905 at ₹30.201.36% of the companyNet −19,479 shares₹22 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 32,90,123 at ₹30.13Sold 32,98,433 at ₹30.150.62% of the companyNet −8,310 shares₹9.91 Cr bought
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 32,18,674 at ₹30.13Sold 32,12,893 at ₹30.160.61% of the companyNet +5,781 shares₹9.70 Cr bought
- Both waysPLUTUS WEALTH MANAGEMENT LLPBought 27,29,252 at ₹29.89Sold 27,29,252 at ₹29.910.51% of the companyNet nil₹8.16 Cr bought
Thursday 24 Sep 20261 firm · ₹14 Cr bought · ₹14 Cr soldNet sold ₹0.47 Cr
- Both waysHRTI PRIVATE LIMITEDBought 46,98,525 at ₹29.20Sold 48,58,932 at ₹29.200.91% of the companyNet −1,60,407 shares₹14 Cr bought
Wednesday 23 Sep 20265 firms · ₹82 Cr bought · ₹85 Cr soldNet sold ₹3.06 Cr
- Both waysIRAGE BROKING SERVICES LLPBought 20,16,657 at ₹29.31Sold 28,75,202 at ₹28.920.54% of the companyNet −8,58,545 shares₹5.91 Cr bought
- Both waysHRTI PRIVATE LIMITEDBought 1,31,94,593 at ₹28.78Sold 1,32,77,172 at ₹29.022.50% of the companyNet −82,579 shares₹38 Cr bought
- Both waysQE SECURITIES LLPBought 53,27,588 at ₹28.76Sold 53,29,218 at ₹28.931.00% of the companyNet −1,630 shares₹15 Cr bought
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 49,95,524 at ₹28.91Sold 49,95,526 at ₹28.920.94% of the companyNet −2 shares₹14 Cr bought
- Both waysMICROCURVES TRADING PRIVATE LIMITEDBought 28,96,608 at ₹28.84Sold 28,96,608 at ₹28.840.54% of the companyNet nil₹8.35 Cr bought
Tuesday 22 Sep 20263 firms · ₹32 Cr bought · ₹36 Cr soldNet sold ₹3.45 Cr
- Both waysNEO APEX SHARE BROKING SERVICES LLPBought 33,30,626 at ₹28.74Sold 45,73,234 at ₹28.860.86% of the companyNet −12,42,608 shares₹9.57 Cr bought
- Both waysQE SECURITIES LLPBought 29,51,499 at ₹28.20Sold 29,21,607 at ₹28.130.56% of the companyNet +29,892 shares₹8.32 Cr bought
- Both waysHRTI PRIVATE LIMITEDBought 51,21,298 at ₹27.93Sold 50,90,236 at ₹27.970.96% of the companyNet +31,062 shares₹14 Cr bought
Monday 21 Sep 20266 firms · ₹82 Cr bought · ₹83 Cr soldNet sold ₹1.75 Cr
- Both waysHRTI PRIVATE LIMITEDBought 67,61,069 at ₹25.00Sold 73,12,743 at ₹25.311.38% of the companyNet −5,51,674 shares₹17 Cr bought
- Both waysQE SECURITIES LLPBought 48,14,607 at ₹24.91Sold 48,87,876 at ₹24.760.92% of the companyNet −73,269 shares₹12 Cr bought
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 78,12,624 at ₹25.09Sold 78,12,199 at ₹25.111.47% of the companyNet +425 shares₹20 Cr bought
- Both waysMICROCURVES TRADING PRIVATE LIMITEDBought 46,68,109 at ₹25.61Sold 46,68,109 at ₹25.640.88% of the companyNet nil₹12 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 51,92,112 at ₹25.20Sold 51,92,112 at ₹25.220.98% of the companyNet nil₹13 Cr bought
- Both waysPLUTUS WEALTH MANAGEMENT LLPBought 32,75,093 at ₹25.01Sold 32,75,093 at ₹25.000.62% of the companyNet nil₹8.19 Cr bought
Friday 18 Sep 20265 firms · ₹85 Cr bought · ₹87 Cr soldNet sold ₹1.58 Cr
- Both waysHRTI PRIVATE LIMITEDBought 1,01,27,829 at ₹23.53Sold 1,07,08,068 at ₹23.632.01% of the companyNet −5,80,239 shares₹24 Cr bought
- Both waysQE SECURITIES LLPBought 48,23,086 at ₹23.44Sold 48,07,580 at ₹23.630.91% of the companyNet +15,506 shares₹11 Cr bought
- Both waysMICROCURVES TRADING PRIVATE LIMITEDBought 32,63,901 at ₹23.52Sold 32,63,901 at ₹23.590.61% of the companyNet nil₹7.68 Cr bought
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 1,28,27,931 at ₹23.56Sold 1,28,21,055 at ₹23.592.41% of the companyNet +6,876 shares₹30 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 51,60,805 at ₹23.52Sold 51,60,805 at ₹23.530.97% of the companyNet nil₹12 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. The latest 57 deals, on record since listing on 3 Sep 2025.